��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Pilot Trial of Rituximab in Myasthenia Gravis

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Rup Tandan, MD, FRCP, FAAN (University of Vermont (UVM)/UVM Medical Center)	Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
	No disclosure on file
	No disclosure on file
Deborah Y. Bradshaw, MD, FAAN (SUNY Upstate Medical University)	The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
	No disclosure on file